Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
236 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Closed (3)

Medical Condition

  • Show all (144)
  • Autoimmune Disorders (3)
  • Blood Disorders (6)
  • Cancer (79)
    • Bladder Cancer (1)
    • (-) Breast Cancer (1)
    • Gastrointestinal (3)
    • Gynecologic Cancer (4)
    • Head and Neck Cancer (2)
    • (-) Kidney Cancer (2)
    • Leukemia (5)
    • Lung Cancer (12)
    • Lymphoma (3)
    • Multiple Myeloma (5)
    • Prostate Cancer (6)
    • Sarcoma (3)
    • Skin Cancer (5)
    • Solid Tumors (5)
  • Diabetes (1)
  • Gastrointestinal and Digestive Diseases (2)
  • Healthy Volunteers (4)
  • Heart Disease (2)
  • Infectious Disease (4)
  • Neurological Disorders (14)
  • Nutrition (1)
  • Obstetrics & Gynecology (1)
  • Pediatrics (14)
  • Psychiatric Disorders (1)
  • Transplant (11)
  • Urology (1)
Displaying 1 - 3 of 3

FRACTION: Study of Drug Combinations in Patients with Advanced Renal Cell Carcinoma

Condition: Cancer / Kidney Cancer
Investigator: Emerson Lim, MD
Status: Closed
We are doing this study to test a drug called MGD009. MGD009 is like an antibody, which is a protein in your blood that helps get rid of germs in your body. MGD009 is made to attach to cancer cells and to T-cells, which are a part of your immune system. Certain T…
Read More

Study of Antibody Drug in Patients with Advanced Renal Cell Carcinoma

Condition: Cancer / Kidney Cancer
Investigator: Mark Stein, MD
Status: Closed
This research study is a phase II clinical trial. Phase II clinical trials test the safety and effectiveness of an investigational treatment to learn whether the intervention works in treating a specific disease. Investigational means that the intervention is being studied. The Food and Drug Administration (FDA) has approved Nivolumab as treatment for…
Read More

TrACER: Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) for Patients Receiving Chemotherapy

Condition: Cancer / Breast Cancer
Investigator: Dawn Hershman, MD
Status: Closed
This randomized clinical trial studies prophylactic colony stimulating factor management in patients with breast, colorectal or non-small cell lung cancer receiving chemotherapy and with risk of developing febrile neutropenia. Patients receiving chemotherapy may develop febrile neutropenia. Febrile neutropenia is a condition…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science